Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (29)

« Back to Publications

TBX15 regulates a network of immune response genes in adipose tissue and alters fat mass and depot weight in heterozygous knockout mice

Zolkiewski L. et al, (2024)

Synthesis of Aryl-fused Bicyclo[3.1.1]heptanes (BCHeps) and Validation as Naphthyl Bioisosteres

Kerckhoffs A. et al, (2024)

missense mutation in zinc finger homeobox-3 (ZFHX3) impedes growth and alters metabolism and hypothalamic gene expression in mice.

Nolan PM. et al, (2023), FASEB J, 37

Long-Acting PTH/PTHrP Hybrid Analogue Rectifies Hypocalcemia in a Mouse Model for Autosomal Dominant Hypocalcemia Type-1 (ADH1)

Hannan F. et al, (2023), JOURNAL OF BONE AND MINERAL RESEARCH, 38, 31 - 31

missense mutation in zinc finger homeobox-3 (ZFHX3) impedes growth and alters metabolism and hypothalamic gene expression in mice

Nolan PM. et al, (2022)

Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.

Chatzopoulou M. et al, (2020), ACS Med Chem Lett, 11, 2421 - 2427

2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.

Babbs A. et al, (2020), J Med Chem, 63, 7880 - 7891

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid.

Wilkinson IVL. et al, (2020), Angew Chem Int Ed Engl, 59, 2420 - 2428

Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model.

Babbs A. et al, (2020), Tetrahedron, 76

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.

Guiraud S. et al, (2019), Hum Mol Genet, 28, 2189 - 2200

Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.

Guiraud S. et al, (2019), Hum Mol Genet, 28, 307 - 319

Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice.

Kennedy TL. et al, (2018), Mol Ther Methods Clin Dev, 11, 92 - 105

genetic modifier suggests that endurance exercise exacerbates Huntington's disease.

Corrochano S. et al, (2018), Hum Mol Genet, 27, 1723 - 1731

Small molecule utrophin modulators for the therapy of Duchenne muscular dystrophy (DMD)

Russell A. et al, (2018), ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 256

Disruption of the homeodomain transcription factor orthopedia homeobox (Otp) is associated with obesity and anxiety.

Moir L. et al, (2017), Mol Metab, 6, 1419 - 1428

Load More